The role of insulin (INS), and insulin-like growth factor-I (IGF-I
Introduction
The formation of red blood cells is regulated by various cytokines and growth factors. Of these, erythropoietin (EpO) is absolutely required for survival and differentiation of the erythropoietic progenitors. [1] [2] [3] Other growth factors, and cytokines such as insulin (INS), insulin-like growth factors (IGF-I, IGF-II), basic fibroblast growth factor (FGF-2), hepatocyte growth factors (HGF), prolactin (PRL), interleukins (IL-3, IL-4, IL-6, IL-9, IL-11), granulocyte-monocyte stimulatory factor (GM-CSF), and kit ligand (KL), have been reported to co-stimulate with EpO the growth of the erythroid colonies. [4] [5] [6] [7] [8] [9] [10] [11] Since several of these factors including KL, INS and IGF-I, are usually present in the serum used to supplement cell culture media, contribution of the individual factors to erythropoiesis in experiments performed in serum supplemented conditions has been difficult to assess. The fact that EpO alone fails to stimulate BFU-E in serum-free conditions, but does do in serum containing cultures indicates that serum contains some crucial growth factors necessary for the BFU-E development.
In previous studies from our laboratory, we examined the role of IGF-I 12 and KL 9, 11, 13 in the regulation of early human erythropoiesis. Both of these growth factors are considered to be crucial for the BFU-E growth. 3, 6, 8, 14 Unexpectedly, that addition of IGF-I to cultures of the purified human CD34
+ cells did not enhance formation of the hematopoietic colonies. 12 Similarly, downregulation of IGF-I R using antisense oligodeoxynucleotides was without any apparent effect on the growth of normal human hematopoietic progenitors. In contrast, antisense oligodeoxynucleotides against c-Kit R totally inhibited the BFU-E colony formation, if CD34
+ cells were costimulated with EpO + KL alone. 9, 11, 13 We concluded therefore, that KL, but not IGF-I, is a critical regulator of human erythroid colony formation. We concluded also, that EpO is not able to support BFU-E colony growth 11 if KL is not present in the cultures. This last observation was recently confirmed in several elegant studies by the other investigators. [1] [2] [3] Nevertheless, since our previous studies were performed in the presence of serum, which is known to contain INS, 8 the effect of IGF-I on colony formation was uncertain. As it is well known, INS, IGF-I and IGF-II show a high degree of the molecular homology, and crossreact with their corresponding receptors. In addition, INS R and IGF-I R are structurally related heterodimers, which possess intrinsic tyrosine kinase activity, and after interaction with IRS-1 and IRS-2 'docking proteins' activate appropriate signal transduction proteins. In contrast, the third receptor of this family, IGF-II R, is a single highly glycosylated transmembrane peptide, which does not possess tyrosine kinase activity. The ability of IGF-II R to recruit signal transduction proteins is not well documented in the literature. 15 To learn more about the role of the insulin growth factor family in regulating human erythropoiesis, we employed a well-defined serum-free cloning system to examine the direct effect of INS and IGF-I on survival and cloning efficiency of the CD34 + cells. We also studied the development of BFU-E colonies compared to the effect of other cytokines and growth factors which have been reported to enhance erythropoiesis. 4, 6, [16] [17] [18] [19] Finally, we analyzed by FACS and RT-PCR the expression of INS-R and IGF-IR in the early progenitor cells and their more differentiated, cultured derivatives. Our results suggest that neither INS nor IGF-I are critical for human erythropoiesis. These factors seem to inhibit apoptosis in the human early hematopoietic cells but do not appear to affect the initial proliferation and differentiation of these cells. INS and IGF-I may, however contribute more effectively to the final maturation of erythroid colonies.
Materials and methods

Oligodeoxynucleotides (ODN)
Unmodified 18-base ODN were synthesized on an Applied Biosystems (Foster City, CA, USA) 380B DNA synthesizer by means of ␤-cyanoethyl phosphoroamidite chemistry as described. ODN were purified by ethanol precipitation and multiple washes in 70% ethanol, lyophilized to dryness, and re-dissolved in culture medium at a concentration of 1 mg/ml (0.167 mmol/l). ODN sequences utilized were based on the published human IGF-I R sequence, 20 and were targeted to codons −21−26 of the pro-receptor signal peptide: antisense ODN; 5′-TCC TCC GGA GCC AGA CTT-3′, sense ODN: 5′-AAG TCT GGC TCC GGA GGA-3′ and scrambled ODN; 5′-TGA GAC TCC TTA CCG CCG-3′ as described. 21 
Cells
Light-density marrow mononuclear cells (MNC) were obtained from 11 consenting healthy donors and depleted of adherent cells and T lymphocytes (A-T-MNC) as described. [10] [11] [12] 22 Cell lines Chinese-hamster ovary (CHO) cell line transfected with human INS-R was made available to us by P Rothenberg from the University of Pennsylvania. HTLV-1 positive T cell lines: HUT-102B and C91PL were obtained from G Trinchieri from Wistar Institute, Philadelphia, and M Kamoun from the University of Pennsylvania, respectively. The EBV-transformed lymphoblastoid B cell line (LCL) was described previously. 23, 24 Cell cultures Briefly, (10 4 ) CD34 + A-T-BMNC cells were cloned in 1 ml of medium containing 0.8% methylcellulose (Methocel MC, Fluka, Switzerland) in Iscove's modified Dulbecco's medium (IMDM) (Gibco BRL, Grand Island, NY, USA) supplemented with 1% delipidated, deionized, and charcoal stripped bovine serum albumine (BSA) (Sigma, St Louis, MO, USA), or albumin bovine RIA grade (INS Ͻ0.1 mU/mg) (Sigma), 270 g/ml ironsaturated transferrin (Sigma), 5.6 g/ml cholesterol (Sigma) and 2 mmol/l l-glutamine. The appropriate growth factors were added to the mixture which was then transferred to 3.5-cm plastic petri dishes and incubated (37°C, 95% air, 5% CO 2 humidified atmosphere) for the times appropriate to the colonies being grown. Exogenous growth factors were employed as follows: erythropoietin (Epo; 5 U/ml) + interleukin-3 (IL-3; 20 U/ml), or EpO + kit ligand (KL; 100 ng/ml) for BFU-E, IL-3 (20 U/ml) + granulocyte-macrophage colony-stimulating factor (GM-CSF; 5 ng/ml) for CFU-GM, Epo (5 U/ml) + IL-3 (20 U/ml) + GM-CSF (5 ng/ml) + KL (100 ng/ml) for CFU-Mix. In some experiments BFU-E growth was co-stimulated with the optimal doses of following factors: INS (5-10 g/ml), IGF-I (50 ng/ml), IGF-II (50 ng/ml), FGF-1 (50 ng/ml), FGF-2 (100 ng/ml), leukemia inhibitory factor (LIF, 50 ng/ml), IL-1␣ (100 pg/ml), IL-1␤ (100 pg/ml), IL-4 (50 ng/ml), IL-6 (80 U/ml), IL-9 (100 ng/ml), IL-11 (100 U/ml), VEGF (vascular endothelial growth factor, 20 ng/ml), PRL (20 ng/ml), STK-1L (stem cell tyrosine kinase-1 receptor ligand, 20 ng/ml), HGF (hepatocyte growth factor, 20 ng/ml), G-CSF (10 ng/ml), GM-CSF (5 ng/ml), IL-3 (20 U/ml) and KL (100 ng/ml). Recombinant human growth factors were used in all experiments (R&D, Minneapolis, MN, USA). Colonies were counted with an inverted microscope on day 11 (CFU-GM), on day 14 (BFU-E), and on day 15 (CFU-Mix).
In some experiments cells were cultured in serum-free conditions with or without exogenously added insulin (20 g/ml) for 7 days before growth factors were added to stimulate growth of CFU-Mix, BFU-E and CFU-GM colonies.
Cell selection and mRNA isolation A-T-MNC were enriched for CD34
+ cells by immunoaffinity selection with murine monoclonal antibody HPCA-1 (Becton Dickinson, San Jose, CA, USA) and magnetic beads according to the manufacturer's protocol (Dynal, Oslo, Norway). The ckit R + subset of CD34 + cells was isolated by FACS. In brief, 2 × 10 7 human A-T-MNC were suspended in PBS supplemented with 5% bovine calf serum (Hyclone, Logan, UT, USA) (BCS) and labeled for 30 min at 4°C with anti-c-kit R monoclonal antibodies (SR-1) (1:1000) (generously provided by V Broudy, University of Washington, Seattle, WA, USA). Cells were washed three times in ice-cold PBS supplemented with 5% BCS and then incubated with phycoerythrin (PE)-conjugated goat anti-mouse monoclonal antibody (Sigma) 
FACS analysis of cultured cells for INS-R and IGF-IR expression
Cells from day 6 or day 9 BFU-E and CFU-GM colonies were isolated from serum-free methylcellulose cultures by aspiration with a Pasteur pipette, washed twice in ice-cold PBS supplemented with 5% BCS before incubation with anti-INS-R Ab (1:2000) or IGF-1R Ab (1:100), followed by PE-conjugated goat anti-mouse monoclonal antibody (Sigma) (1:100) for 30 min at 4°C. After incubation, cells were again washed three times in ice-cold PBS supplemented with 5% BCS and subjected to analysis using a FACS Star Plus II (Becton Dickinson).
Detection of apoptosis (10 5 ) were isolated by FACS and then resuspended in Iscove DMEM containing the serum-free supplement described above. The cells were cultured in 6-well plastic plates in the presence or absence of INS (20 g/ml) for 72 h (37°C, 95% humidity, 5% CO 2 ) and then washed once in PBS and fixed in 4% neutral-buffered formalin. After fixation, the cells were sedimented by gravity onto slides covered with Cell-Tak tissue adhesive (Collaborative Biomedical Products, Bedford, MA, USA). Apoptosis was detected in these cells using in situ apoptosis detection kit: ApopTag (Oncor, Gaithersburg, MD, USA) according to the manufacturer's protocol. In this assay, terminal deoxynucleotide transferase (TdT) is used to label the fragmented ends of DNA which has undergone apoptosis with digoxigenin-dUTP. The digoxigenin label is subsequently detected with a fluorescently labeled anti-digoxigenin antibody allowing simple, direct enumeration of apoptotic cells with a fluorescence microscope.
ODN exposure and cell cultures
Cells were exposed to ODN as described. [10] [11] [12] 22 Briefly, CD34
+ MNC (2 × 10 4 ) were incubated in 0.4 ml of IMDM supplemented with 1% BSA without serum in polypropylene tubes (Fisher Scientific, Pittsburgh, PA, USA). ODN (100 mg/ml) were added at time zero, and 50% of the initial dose was added 18 h later (final concentration ෂ26 M). Twenty-four hours after the first addition of ODN, cells were plated in serum-free methylcellulose cultures without further washing.
Detection of phosphorylation of the IRS protein
The assay was performed essentially as described before. 23, 24 In brief, cells (10 7 ) were exposed to 5 mM of INS (Sigma), 100 ng/ml of IGF-I (R&D), or medium for 5 min at 37°C, lysed for 20 min in 1 ml ice-cold lysis buffer and centrifuged at 15 000 r.p.m. The supernatants were preclared overnight at 4°C with protein A-sepharose (Sigma). The anti-IRS-2 antibody (kind gift of Dr Xiao Sun, Joslin Diabetes Center, Boston, MA, USA) was added, following by the protein A-sepharose to precipitate the immune complexes. The immunoprecipitates were separated on a 10% polyacrylamide-SDS gel, and transferred electrophoretically onto hybridization membranes. The membranes, were incubated with the murine 4G10 anti-phosphotyrosine monoclonal antibody (UBI, Lake Placid, NY, USA) followed by the peroxidase-conjugated anti-mouse Ab (Jackson Immuno-Research, West Grove, PA, USA). Blots were developed using the ECL chemiluminescence reagents (Amersham Life Science, Arlington Heights, IL, USA). Autoradiographs were quantitatively analyzed using a Molecular Dynamics Densitometer and Imagequant Version 3.22 software (Molecular Dynamics, Sunnyville, CA, USA).
Isolation of mRNA from BFU-E and CFU-GM BFU-E and CFU-GM colonies grown in serum-free methylcellulose cultures were analyzed for INS-R and IGF-IR expression by RT-PCR. Briefly, colonies were picked from day 6 to day 9 cultures using a Pasteur pipette under an inverted microscope. Randomly selected colonies (ෂ20) from each culture dish were picked for each mRNA extraction. Colonies were resuspended in 10 ml of IMDM and incubated for 1 h at 37°C to dissolve the methylcellulose, centrifuged, washed twice in PBS, and mRNA was extracted. In brief, using QuickPrep Micro mRNA Purification Kit (Pharmacia Biotech), according to the manufacturer's protocol cells from 20 colonies were lysed in 200 l of RNAzol (Cinna-Biotecx, Houston, TX, USA) + 22 l of chloroform. The aqueous phase was collected and mixed with 1 volume of isopropanol (Sigma). RNA was precipitated overnight at −20°C. The RNA pellet was washed in 75% ethanol and resuspended in three times autoclaved H 2 O.
Reverse transcriptase-polymerase chain reaction (RT-PCR)
RT-PCR was carried out as described. [10] [11] [12] 22 Briefly, mRNA (0.5 g) was reverse-transcribed with 500 U of Moloney murine leukemia virus reverse transcriptase (MoMLV-RT) and 50 pmol of an ODN primer complementary to the 3′ end of the following sequence of IGF-IR (nts 1641-1659): ATA CTC TGT GAC ATT CTT AA or INS R (nts 881-859): CAG TCC TGG AAG TGG TAG TAC. The resulting cDNA fragments were amplified using 5 U of Thermus aquaticus (Taq) polymerase and primers specific for the 5′ end of IGF-IR: nts 1063-1082 (ACC ATT GAT TCT GTT ACT TC) or for the 5′ end of INS-R:
19 nts 170-192 (GGA ACA ACC TCA CTA GGT TGC A). ␤-actin mRNA was amplified simultaneously using specific primers as described. Amplified products (10 l) were electrophoresed on a 2% agarose gel, and transferred to a nylon filter. Filters were pre-hybridized and probed with a 32 P end-labeled ODN specific for the cDNA of IGF-I R (nts 1131-1149) (CTG CTC CTC TCC TAG GAT GA), and INS-R (CCT TGA GGT GAA CCA TCT CGA AGA TGA) (nts 409-436). Hybridization was detected by autoradiography as described. [10] [11] [12] 22 Statistical analysis Arithmetic means and standard deviations were calculated on a MacIntosh computer using Instat 1.14 (GraphPad, San Diego, CA, USA) software. Experiments were performed on cells obtained from 11 healthy donors. Cells at each time point were cultured in quadruplicate. Data were analyzed using the Student's t-test for unpaired samples. Statistical significance was defined as P Ͻ 0.01.
Results
INS and IGF-I inhibit the apoptotic death of CD34
+ cells To examine the effect of INS and IGF-I on the growth and survival of the early progenitor hematopoietic cells, we cultured the CD34 + cells for 7 days under serum-free conditions in methylcellulose cultures in the presence of insulin (20 g/ml), IGF-I (50 ng/ml) or medium alone. We noted, that during this period of time, CD34
+ cells did not proliferate even if exposed to the INS or IGF-I.
After 8 days in serum-free culture, cells were stimulated with the following combinations of cytokines: KL+IL-3+EpO+GM-CSF, EpO+KL, and IL-3+GM-CSF to obtain, respectively, CFU-Mix, BFU-E, and CFU-GM colonies. As depicted in Table 1 , the addition of INS significantly increased the survival of all progenitors tested, which were cultured for 7 days under serum free conditions (Table 1) . Roughly, twice as many colony-forming cells were recovered when insulin was added to the serum-free culture medium. Similar results were obtained using IGF-1 (data not shown). Therefore, while INS and IGF-I did not stimulate the proliferation of human CD34 + cells, both of these growth factors did enhance the survival of CD34
+ progenitors cultured under serum-free conditions. Since both INS and IGF-I similarly enhanced the survival of the various progenitors evaluated in this study (CFU-Mix, BFU-E, CFU-GM), this pro-survival effect does not seem to be lineage specific.
Next we wondered if the pro-survival effect of INS is dosedependent. To address this issue, we cultured CD34
+ cells in serum-free medium in the presence of increasing doses of INS (0-100 g/ml). As demonstrated in Figure 1 , the anti-apoptotic effect of INS becomes apparent at 1 g/ml, and reaches a maximum at 10-20 g/ml. This concentration of INS significantly improved the survival (P Ͻ 0.0001) of the human hematopoietic progenitors from all of the evaluated lineages. Further increases in INS concentration did not improve survival of the CD34 + cells. To directly determine if INS effected the viability of progenitor cells, and to determine whether this enhancement occurs by inhibiting apoptotic death of these cells, highly enriched in stem/early progenitor cells CD34 + , Kit-R + marrow cells were isolated by FACS. Figure 2 shows results of a typical multiparameter sort. The lymphocytic region, R3, was identified by low forward and orthogonal scatter analysis of the cells (Figure 2a ). Within this region, cells were further analyzed for co-expression of c-kit R and CD34 antigen (Figure 2b ). Positivity was determined by comparison with isotype-matched antibody-labeled control cells. R1 delineates cells co-expressing both markers in the dual-labeled population (Figure 2c ). Only those cells that satisfied R3 and R1 criteria were sorted and used in our experiments. The sorted population was Ͼ95% pure (Figure 2d) . To evaluate the influence of INS on survival of human early progenitors cultured under serum-free conditions, the CD34 + , Kit-R + cells sorted by FACS were subsequently cultured for 72 h in serum-free medium in the presence or absence of INS. As shown in Table 2 , the number of apoptotic cells was much greater in the cells cultured for 72 h in the absence of INS (P Ͻ 0.01). These data support our assumption, that the addition of INS to CD34
+ Kit-R + cells appeared to augment the viability of hematopoietic progenitors by preventing them from undergoing apoptosis (Figure 3 ). This observation has also an important practical implication suggesting that INS should be added as an anti-apoptotic growth factor to the culture media employed for growing and expanding human CD34 + cells.
Erythroid colony formation in serum-free, INSsupplemented cultures
In contrast to serum supplemented cultures, 4 EpO when used alone is unable to stimulate formation of human BFU-E under serum-free conditions. 24 This difference most probably reflects the presence of biologically active concentrations of some growth factors present usually in the fetal serum component of the culture medium. Several reports suggested that INS and/or IGF-I are required to costimulate with EpO erythroid colony formation in serum-free cloning medium. 5, 8, [17] [18] [19] [26] [27] [28] [29] [30] [31] Nevertheless, we were not able to reproduce this observation when CD34
+ cells were cultured in our serum-free culture system. Therefore, we sought to identify cytokines which would be able to co-stimulate with EpO the formation of BFU-E colonies under serum-free culture conditions (Table 3) . Therefore, to determine the effect of different growth factors on BFU-E colony formation, CD34
+ cells were plated in serumfree methylcellulose containing EpO and INS, and various growth factors previously reported to augment erythropoiesis: IGF-I, IGF-II, FGF-1, FGF-2, HGF, LIF, IL1␣, IL-1␤, IL-4, IL-6, IL-9, IL-11, G-CSF, GM-CSF, STK-1L, IL-3 and KL.
We observed that the addition of most of these growth factors to EpO + INS did not stimulate BFU-E colony formation in our serum-free model ( Table 3 ). The only exceptions were KL, IL-3, GM-CSF and IL-9. KL was found to be the most potent stimulator of BFU-E growth under these culture conditions. IL-3, GM-CSF and IL-9 were only partially able to substitute for KL. The number and size of BFU-E colonies after stimulation with these growth factors were, however, always smaller than after stimulation with KL, even when all these growth factors were added to the cultures in combination (Epo + IL-3 + GM-CSF + IL-9) (data not shown).
The effect of KL and the other three factors was strictly EpO dependent because none of them was able to stimulate formation of BFU-E either alone or in combination (KL + IL-3 + GM-CSF + IL-9; data not shown).
Figure 1
Effect of increasing doses of INS (0-100 g/ml) on survival of clonogenic progenitors. Bone marrow CD34 + cells were cultured first for 7 days under serum-free conditions, and at day 7 cells were stimulated with appropriate growth factors to grow CFU-Mix (a), BFU-E (b) and CFU-GM (c) colonies as described in the Materials and methods section. Data are pooled from three independent experiments performed on normal marrow cells, plated in quadruplicate.
Figure 2
Representative FACS analysis of bone marrow MNC double-labeled for CD34 antigen (FITC) and c-kit receptor (PE). 
Effect of exogenous INS on hematopoietic colony formation in serum-free cultures
As noted above, we found that INS if added alone to human CD34 + cells cultured under serum-free conditions, did not stimulate their proliferation. Moreover, we found employing our serum-free culture system that the addition of both INS and/or IGF-I were insufficient to costimulate EpO-dependent Table 2 The effect of insulin (INS) on inhibiting apoptosis in the bone marrow CD34 
BFU-E colony formation. To clarify the role of INS in the formation of erythroid colonies, we next evaluated the influence of INS on erythroid colony formation by CD34
+ cells cultured serum-free after stimulation with the mixture of EpO + KL or Epo + IL-3.
We observed that the effect of INS on human erythroid colony formation was strongly dependent on the combination of growth factors used to costimulate BFU-E growth. It was bigger if the BFU-E cultures were stimulated sub-optimally (EpO + IL-3), and smaller if they were stimulated more optimally (EpO + KL). Accordingly, the number of colonies formed after stimulation with EpO + IL-3 and supplemented with INS was approximately 30% higher as compared (145 ± 45) to cultures without INS (97 ± 24), and colonies were also larger in size (data not shown). By contrast, addition of insulin to EpO + KL had no significant effect on colony number (304 ± 83 vs 299 ± 79) although colony size was increased in these cultures when INS was present.
Since we have employed INS-free albumin for preparing our serum-free medium, the fact that even in the complete absence of INS or IGF-I normally hemoglobinized erythroid colonies developed after stimulation with EpO + KL or EpO + IL-3, indicates that neither INS nor IGF-I are required for development of human erythroid colonies. Effect of delayed addition of insulin on growth of CD34 + cells in serum-free cultures
The finding that INS and IGF-I can augment the size of BFU-E colonies indicates that both these growth factors may costimulate proliferation of the more differentiated erythroid progenitors. Therefore, in order to determine whether insulin affects the terminal maturation of erythroid colonies, we examined BFU-E colony growth stimulated with EpO + IL-3, when insulin (10 g/ml) was either not added or added at day 0, 6 or 9 to the cultures ( Table 4) . Addition of insulin at day 6 fully restored the number of BFU-E colonies, and such colonies also achieved normal size compared to those grown in supplemented with insulin at day 0 serum-free cultures. Addition of IGF-I (50 ng/ml) at day 6 also restored the number of BFU-E colonies (data not shown). Similarly, when BFU-E colonies were grown in serum-free medium stimulated with EpO + KL, addition of insulin at day 6 and 9 restored colonies to their normal size (data not shown). These data show that INS or IGF-I stimulate the proliferation and maturation of more differentiated erythroid progenitor cells.
Expression of INS and IGF-I receptors on CD34
+ early human hematopoietic cells and more mature hematopoietic cells isolated from BFU-E, and CFU-GM colonies Next, expression of INS-R and IGF-1R was evaluated in the more mature hematopoietic cells derived from CFU-GM and BFU-E colonies. For this purpose, CD34
+ cells were plated in the serum free-medium and stimulated with the appropriate growth factors to form BFU-E or CFU-GM colonies. Individual colonies were isolated at days 6 and 9, and analyzed by RT-PCR. mRNA for INS-R was detected in all samples ( Figure 5 ). In contrast to CD34 + , c-kit R + cells, IGF-1R mRNA was readily detectable in the cells isolated from day 6 BFU-E and CFU-GM colonies ( Figure 6 ).
Similar results were obtained when cells isolated from day 6 and day 9 CFU-GM and BFU-E colonies were stained with fluorochrome-conjugated anti-INS-R and anti-IGF-1R antibodies. As shown in Figure 7 , both INS-R and IGF-1R were easily detectable by FACS analysis on the cells isolated from day 6 BFU-E and CFU-GM colonies. These data suggest that Table 4 Effect of insulin (10 g/ml) on BFU-E formation by CD34 INS-R is expressed at all stages of hematopoiesis, whereas IGF-IR is not detectable at the earliest progenitors but appears on the more differentiated cells.
INS-and IGF-I-induced signal transduction in erythroid precursors
A novel protein, insulin receptor substrate (IRS-2, 4PS) which is involved in the signaling by INS, IL-4 and probably other, similar factors, has been recently characterized. 32 To provide additional evidence that INS and IGF-I are able to stimulate differentiated erythroid cells, we analyzed BFU-E-derived cells for phosphorylation of the IRS-2 upon exposure to these factors. As shown in Figure 8 
Effect of antisense ODN targeting IGF-IR on INS influence on formation of BFU-E colonies
Because IGF-IR was easily detectable in the more mature erythroid cells (Figures 6 and 7) , it is uncertain whether INS exerted its effect through its own receptor, INS-R, or structurally related IGF-I R. 33 To address this question, we perturbed IGF-IR expression in BFU-E colonies with sequence-specific antisense ODN. Downregulation of IGF-IR mRNA expression (Figure 9 ), did not influence the number (mean ± s.d.) of BFU-E stimulated with EpO + KL (240 ± 65 vs 242 ± 80) or EpO + IL-3 (112 ± 39 vs 113 ± 36) that arose in the absence of presence of the IGF-IR antisense ODN, respectively. It is also important to note that none of the control ODN employed (sense, scrambled) affected colony formation (data not shown).
These data show that INS is able to influence the maturation of the erythroid progenitors stimulating its own, but not necessarily structurally related IGF-I R.
Discussion
We report here that the INS-R was detected on both mRNA and protein level on a highly enriched CD34 + , c-kitR + stem/progenitor cell population, and on cells isolated from hemopoietic colonies. In contrast, IGF-IR was detected only on the more mature cells isolated from day 6 BFU-E and CFU-GM colonies. The fact that INS and IGF-I receptors are expressed on erythroid cells was already suggested earlier by other investigators who found that the cells isolated from BFU-E colonies bind radiolabeled INS and IGF-I. 34 Our data additionally indicate that IGF-IR expression in contrast to INS-R expression may correlate positively with differentiation and maturation status of the hemopoietic cells. In agreement with this suggestion, it was recently reported that the IGF-IR expression increases on human B lymphocytes along with their maturation to the plasma cells. [35] [36] [37] We also found that CD34
+ cells if plated under serum-free conditions, do not proliferate when stimulated with INS or IGF-I alone. However, addition of either of these growth factors to serum-free medium appears to increase survival and viability of these cells. These findings, as well as our previously published data 10, 11, 22 demonstrate that receptors with intrinsic tyrosine kinase activity might mediate a signal preventing CD34
+ cells from undergoing apoptosis. Moreover, since IGF-IR was not detectable, in our hands, on CD34 + cells, we can assume that the effect of IGF-I to inhibit apoptosis in CD34
+ cells could be a result of stimulation of structurally related INS-R by IGF-I. 26, 33 The observation that INS provides only partial protection from apoptosis suggests that other factors play a role in survival of the hematopoietic progenitor cells. These factors could include specific signals delivered by other hematopoietic growth hormones and cytokines, or signals generated after interaction of adhesion molecules expressed on early hematopoietic cells with their appropriate ligands present in hematopoietic microenvironment. Most, or specific combination(s) of these factors might be required for the optimal survival of the CD34 + cells. We also noted with interest that CD34
+ cells stimulated with EpO + INS or EpO + IGF-I did not form BFU-E colonies in serum-free cul- tures. This observation is in apparent discordance with previously published data, 5, 8, [17] [18] [19] [26] [27] [28] [29] [30] [31] and could be partially explained by the fact that in our study we have been cloning bone marrow CD34 + cells, depleted from hematopoietic accessory cells. These latter cells could secrete KL or IL-3 and/or other factors which can co-stimulate growth of the BFU-E colonies.
From all the growth factors and cytokines we have tested, only KL, and to a much lesser degree IL-3, GM-CSF and IL-9, costimulated EpO-dependent growth of BFU-E. These data confirm that KL is the major regulator of erythropoiesis. This extends our previous observation, 10, 11 that downregulation of c-kit R on human CD34
+ cells completely inhibits BFU-E growth, even if EpO is present in the cultures. 11 The fact that IL-3, GM-CSF and IL-9 are able to costimulate with EpO erythropoiesis to some degree may explain why profound anemic w and sl mutant mice, which have defects in KL-ckit R axis, still show some level of erythropoiesis. 13 We also evaluated the effect of INS and IGF-1 on the later stages of erythroid colony formation. Both growth factors if added to the cultures of CD34 + cells, which were stimulated 'suboptimal' with EpO + IL-3, augmented slightly formation of hemoglobinized colonies. This effect was not previously observed in our serum supplemented cloning system, 12 which was probably 'contaminated' by INS present in the serum. 8, 38 We also found, that when the IGF-1R expression was downregulated using an antisense strategy, the effect of INS on the late development of BFU-E colonies was still preserved. This suggests that INS acted through its own INS-R and not through the structurally similar IGF-1R. Moreover, this weak erythropoietic effect of INS, and IGF-I was observed even when INS or IGF-1 was added to the culture medium as late as day 6 after plating. At this time point the growth of BFU-E colonies is already established, and the cells present in BFU-E colonies do not express any more CD34 antigen. Moreover, we documented that INS and IGF-I activated signal transduction in maturing human erythropoietic cells as determined by phosphorylation of the insulin receptor substrate-2 (IRS-2) protein. 32 All these data together suggest that both INS and IGF-I in contrast to KL exert their effects predominantly during the latter stages of erythropoiesis. A recent report that INS and IGF-I stimulate the maturation and differentiation of cells from the erythroid lineage is in agreement with the data presented here. 28 A growing body of data suggests that the role of the insulin growth factor family in the regulation of the early stages of hemopoiesis might be over-stated. Accordingly, mice with deletional mutations of genes encoding IGF-I, IGF-2, IGF-R and IRS-1, [39] [40] [41] [42] [43] Laron dwarf patients with drastically reduced IGF-I levels 44 or acromegalic patients with elevated IGF-I levels, all show normal erythropoiesis. 45 Moreover, the individuals with an inherited absence of INS-R, 46, 47 and IGF-I 48 were found to also be hematologically normal. Finally, the patients treated with IGF-I for dwarfism or AIDS-related wasting syndrome, 49 similarly like diabetics receiving INS, do not show any signs of erythroid hyperplasia.
We conclude therefore, that the role of the insulin growth factor family in regulating human erythropoiesis is probably RT-PCR analysis of IGF-IR expression in day 9 BFU-E growing in serum-free methylcellulose medium. C, control cells not exposed to oligomers; S, A, Scr, cells exposed to sense, antisense and scrambled ODN sequence, respectively, targeted against IGF-IR mRNA.
over-estimated in the literature. Our data also further strengthen the role of KL as the most critical regulator of BFU-E development. Without KL, BFU-E do not form colonies in serum-free medium even if supplemented with EpO and INS or IGF-I. In fact it was reported recently, that both EpO-R and c-Kit R signaling pathways are necessary for normal erythropoiesis. [1] [2] [3] Of all the growth factors tested, only IL-3, GM-CSF and IL-9 could partially replace the KL function. We also demonstrated that, in contrast to KL, both INS and IGF-I are most important for late erythroid maturation, acting on cells more mature than CD34
+ . In 'sub-optimal' stimulatory conditions, both growth factors are able to increase proliferation of maturing erythroid precursors slightly, and speed up the process of their hemoglobinization. Nevertheless, even in the total absence of both insulin and IGF-I, EpO + KL are sufficient to stimulate complete development of BFU-E. Finally, our antisense data indicate that this weak erythropoietic effect of INS is mediated through its own receptor, and not through structurally related IGF-I R. 33 
